semaglutide for alzheimer's may reduce risk in diabetics Semaglutide ineffective in slowing Alzheimer's

Another GLP-1 side effect is reduced appetite

They're both physician-prescribed

The two interventions operate on distinct physiological systems

Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine

In the context of DR, this leads to the phosphorylation of ERK1/2, increasing downstream expression of anti-apoptotic genes like BCL2 and reducing the activity of pro-apoptotic markers such as Caspase-3

The US National Academy of Medicine updated estimated average requirements (EARs) and recommended dietary allowances (RDAs) for vitamin B 12 in 1998